Jazz: Q1 Earnings Snapshot

DUBLIN (AP) _ Jazz Pharmaceuticals PLC (JAZZ) on Tuesday reported first-quarter net income of $121.8 million, after reporting a loss in the same period a year earlier.

The Dublin-based company said it had net income of $2.09 per share. Earnings, adjusted for one-time gains and costs, were $3.92 per share.

The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $3.69 per share.

The drugmaker posted revenue of $607.6 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $606.6 million.

Jazz expects full-year earnings in the range of $15.65 to $16.85 per share, with revenue in the range of $2.55 billion to $2.7 billion.

Jazz shares have fallen nearly 3% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $160.20, a rise of 47% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on JAZZ at https://www.zacks.com/ap/JAZZ